Alibaba injects $488 million health food assets into Ali Health

Reuters  |  HONG KONG 

(Reuters) - Ltd said on Friday controlling shareholder Group Holding Ltd would sell HK$3.8 billion ($488.3 million) worth of food and nutritional products businesses to the company, further developing it into Alibaba's healthcare flagship platform.

will buy JK Nutritional Products Ltd from Group in a deal to be settled by the issue of 1.19 billion shares at HK$3.2 apiece, or a 6.16 percent discount to the last close, the company said in a filing to bourse.

The deal will bring a broader set of merchants into the online healthcare community, while the company will obtain more stable and sustainable revenue growth, the Hong Kong-listed firm added.

saw its adjusted net loss narrowed to 98.3 million yuan ($14.3 million) for the year ended in March, from a 161.5 million yuan loss in the year-ago period amid rapid growth of its pharmaceutical e-commerce business.

($1 = 7.7822 dollars)

($1 = 6.8880 Chinese yuan renminbi)

(Reporting by Donny Kwok; Editing by Stephen Coates)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Alibaba injects $488 million health food assets into Ali Health

HONG KONG (Reuters) - Alibaba Health Information Technology Ltd said on Friday controlling shareholder Alibaba Group Holding Ltd would sell HK$3.8 billion ($488.3 million) worth of health food and nutritional products businesses to the company, further developing it into Alibaba's healthcare flagship platform.

(Reuters) - Ltd said on Friday controlling shareholder Group Holding Ltd would sell HK$3.8 billion ($488.3 million) worth of food and nutritional products businesses to the company, further developing it into Alibaba's healthcare flagship platform.

will buy JK Nutritional Products Ltd from Group in a deal to be settled by the issue of 1.19 billion shares at HK$3.2 apiece, or a 6.16 percent discount to the last close, the company said in a filing to bourse.

The deal will bring a broader set of merchants into the online healthcare community, while the company will obtain more stable and sustainable revenue growth, the Hong Kong-listed firm added.

saw its adjusted net loss narrowed to 98.3 million yuan ($14.3 million) for the year ended in March, from a 161.5 million yuan loss in the year-ago period amid rapid growth of its pharmaceutical e-commerce business.

($1 = 7.7822 dollars)

($1 = 6.8880 Chinese yuan renminbi)

(Reporting by Donny Kwok; Editing by Stephen Coates)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22